For founders seeking funding, the more useful question is not how to win recognition, but how to build trust. What would make a skeptical scientist take the work seriously? What would make a clinician believe it belongs in practice? What would make outcomes measurably better at scale? These are the questions that shape conviction in longevity investing, even if they are less glamorous than a trophy.
At one extreme: if you’re making a prototype or quick script, I reckon all errors are unexpected. You might decide not to handle problems with the network, filesystem, or user input. Who cares? This is just a little script or idea.
。业内人士推荐同城约会作为进阶阅读
FT Professional
ВсеПолитикаОбществоПроисшествияКонфликтыПреступность
This story was originally featured on Fortune.com